4.6 Article

Tessaria absinthioides (Hook. & Arn.) DC. (Asteraceae) Decoction Improves the Hypercholesterolemia and Alters the Expression of LXRs in Rat Liver and Hypothalamus

Journal

METABOLITES
Volume 11, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/metabo11090579

Keywords

brain lipid metabolism; caffeoylquinic acid; dietary fat; nuclear receptors (LXR, PPAR, RXR); UHPLC-PDA-OT-MS/MS phenolic compounds analysis; triglyceride metabolism

Funding

  1. Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
  2. Argentina [PIP-0860, PIP-0243, PIO-SECITI2250, PIO-CONICET SECITI 022]
  3. CICITCA-UNSJ
  4. Fondecyt, Chile [1180059]

Ask authors/readers for more resources

The study showed that Tessaria absinthioides improves cholesterol levels and regulates liver X receptors (LXRs) expression in a hypercholesterolemic model induced by high-fat diet. The chemical profile of T. absinthioides contains various compounds, among which caffeoylquinic acid and its derivatives may play a key role in modifying lipid profiles and LXRs expression. This is the first in vivo study on T. absinthioides, indicating its potential as a candidate against hypercholesterolemia.
Chronic high-fat diet consumption induces hypercholesterolemia. The effect of Tessaria absinthioides (Hook. & Arn.) DC. (Asteraceae) was studied on the levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), and triglycerides, and on the expression of liver X receptors (LXRs) in a hypercholesterolemic model. Adult male rats received a normal diet (ND) or a high-fat diet (HFD; normal diet + bovine fat + cholesterol). After 14 days, rats received water (W) or a decoction of the aerial parts of T. absinthioides (Ta; 10% w/v) for 2, 4, or 6 weeks. Four and six weeks of Ta improved the levels of TC and HDL-c in HFD. After 6 weeks of Ta, the expression of LXRs in HFD was the same as that in ND in both tissues. The Ta chemical profile was studied with an ultrahigh resolution liquid chromatography Orbitrap MS analysis (UHPLC-PDA-OT-MS/MS). Fifty-one compounds were identified, of which twelve are reported for the first time. Among these compounds, caffeoylquinic acid and its derivatives could modify the lipid profile and the expression of LXRs. This is the first in vivo report of T. absinthioides, which may be a potential candidate against hypercholesterolemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available